NCT06510387 Two Bedside Ultrasound Techniques and Standard Methods for Confirmation of Endotracheal Tube Insertion in Intensive Care Patients
| NCT ID | NCT06510387 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Two Bedside |
| Study Type | OBSERVATIONAL |
| Enrollment | 70 participants |
| Start Date | 2023-10-01 |
| Primary Completion | 2024-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 70 participants in total. It began in 2023-10-01 with a primary completion date of 2024-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This cross-sectional observational study aims to predict the sensitivity and specificity of ultrasonography using suprasternal and subxiphoid methods to confirm the correct placement of endotracheal tubes compared to standard methods in intensive care patients.
Eligibility Criteria
Inclusion Criteria: * Patients \> 18 years old. * Both sex. * All patients requiring prophylactic airway management e.g (patient with Glasgow Coma Scale \<8) with endotracheal intubation in the intensive care unit. Exclusion Criteria: * An abnormal airway anatomy. * Tracheal or endobronchial lesion. * Significant cervical trauma. * Cervical abnormality. * Neck swelling. * Patients who need cardiopulmonary resuscitation.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06510387 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Two Bedside. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06510387 currently recruiting?
Yes, NCT06510387 is actively recruiting participants. Contact the research team at eman171629_pg@med.tanta.edu.eg for enrollment information.
Where is the NCT06510387 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT06510387 clinical trial?
NCT06510387 is sponsored by Tanta University. The trial plans to enroll 70 participants.